|
结直肠癌外科治疗进展
|
Abstract:
结直肠癌作为世界范围内最常见的恶性肿瘤之一,发病率和病死率居高不下并呈上升趋势。结直肠癌的外科治疗仍是结直肠癌患者首选的治疗方式,术后辅助化疗及靶向治疗。近年来,随着人们对结直肠解剖认识深入、手术器械的研发、腹腔镜等微创技术的发展,结直肠癌外科治疗手段也在不断进步。因此,本文针对结直肠癌外科治疗手段的进展加以综述,旨在对结直肠外科治疗的发展发挥推动作用。
Colorectal cancer, as one of the most common malignant tumors in the world, has a high incidence rate and mortality which are on the rise. Surgical treatment for colorectal cancer remains the pre-ferred treatment option for colorectal cancer patients, with postoperative adjuvant chemotherapy and targeted therapy. In recent years, with the deepening of people’s understanding of colorectal anatomy, the development of surgical instruments, and the development of minimally invasive technologies such as laparoscopy, surgical treatment methods for colorectal cancer have also been continuously improving. Therefore, this article reviews the progress of surgical treatment methods for colorectal cancer, with the aim of promoting the development of colorectal surgical treatment.
[1] | Benson, A.B., Venook, A.P., Al-Hawary, M.M., et al. (2022) Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 20, 1139-1167.
https://doi.org/10.6004/jnccn.2022.0051 |
[2] | Siegel, R.L., Wagle, N.S., Cercek, A., Smith, R.A. and Jemal, A. (2023) Colorectal Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 233-254. https://doi.org/10.3322/caac.21772 |
[3] | Bretthauer, M., L?berg, M., Wieszczy, P., et al. (2022) Effect of Colonos-copy Screening on Risks of Colorectal Cancer and Related Death. The New England Journal of Medicine, 387, 1547-1556. https://doi.org/10.1056/NEJMoa2208375 |
[4] | Kratzer, T.B., Jemal, A., Miller, K.D., et al. (2022) Cancer Statistics for American Indian and Alaska Native Individuals, 2022: Including Increasing Disparities in Early Onset Colorectal Cancer. CA: A Cancer Journal for Clinicians, 73, 120-146. https://doi.org/10.3322/caac.21757 |
[5] | Yan, H., Talty, R. and Johnson, C.H. (2023) Targeting Ferroptosis to Treat Colorectal Cancer. Trends in Cell Biology, 33, 185-188. https://doi.org/10.1016/j.tcb.2022.11.003 |
[6] | Mo, S., Tang, P., Luo, W., et al. (2022) Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy. Advanced Science (Weinh), 9, Article ID: 2204097.
https://doi.org/10.1002/advs.202204097 |
[7] | Sakata, S. and Larson, D.W. (2022) Targeted Therapy for Colorectal Cancer. Surgical Oncology Clinics of North America, 31, 255-264. https://doi.org/10.1016/j.soc.2021.11.006 |
[8] | He, J., Liu, Y., Liu, C., et al. (2023) A Randomized Phase III Study of Anlotinib versus Bevacizumab in Combination with CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol. Technology in Cancer Research & Treatment, 22, 15330338231152350
https://doi.org/10.1177/15330338231152350 |
[9] | West, N.P., Hohenberger, W., Weber, K., Perrakis, A., Finan, P.J. and Quirke, P. (2010) Complete Mesocolic Excision with Central Vascular Ligation Produces an Oncologically Su-perior Specimen Compared with Standard Surgery for Carcinoma of the Colon. Journal of Clinical Oncology, 28, 272-278. https://doi.org/10.1200/JCO.2009.24.1448 |
[10] | Cervantes, A., Adam, R., Roselló, S., et al. (2023) Meta-static Colorectal Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncolo-gy, 34, 10-32. https://doi.org/10.1016/j.annonc.2022.10.003 |
[11] | Zhao, W., Dai, S., Yue, L., et al. (2022) Emerging Mechanisms Progress of Colorectal Cancer Liver Metastasis. Frontiers in Endocrinology (Lausanne), 13, Article ID: 1081585. https://doi.org/10.3389/fendo.2022.1081585 |
[12] | Islam, M.R., Akash, S., Rahman, M.M., et al. (2022) Colon Cancer and Colorectal Cancer: Prevention and Treatment by Potential Natural Products. Chemico-Biological Inter-actions, 368, Article ID: 110170.
https://doi.org/10.1016/j.cbi.2022.110170 |
[13] | Xu, H., Zhao, H., Ding, C., et al. (2023) Celastrol Suppresses Col-orectal Cancer via Covalent Targeting Peroxiredoxin 1. Signal Transduction and Targeted Therapy, 8, Article No. 51. https://doi.org/10.1038/s41392-022-01231-4 |
[14] | Karpiński, T.M., O?arowski, M. and Stasiewicz, M. (2022) Car-cinogenic Microbiota and Its Role in Colorectal Cancer Development. Seminars in Cancer Biology, 86, 420-430. https://doi.org/10.1016/j.semcancer.2022.01.004 |
[15] | Zhang, C., Stampfl-Mattersberger, M., Ruckser, R. and Sebesta, C. (2023) Kolorektales Karzinom [Colorectal Cancer]. Wiener Medizinische Wochenschrift, 173, 216-220. https://doi.org/10.1007/s10354-022-00975-6 |
[16] | Hryhorowicz, S., Kaczmarek-Ry?, M., Lis-Tana?, E., et al. (2022) Strong Hereditary Predispositions to Colorectal Cancer. Genes (Basel), 13, Article No. 2326. https://doi.org/10.3390/genes13122326 |
[17] | Cheng, V., Oveisi, N., McTaggart-Cowan, H., et al. (2022) Colorectal Cancer and Onset of Anxiety and Depression: A Systematic Review and Meta-Analysis. Current Oncology, 29, 8751-8766. https://doi.org/10.3390/curroncol29110689 |
[18] | Lote, H., Starling, N., Pihlak, R. and Gerlinger, M. (2022) Advances in Immunotherapy for MMR Proficient Colorectal Cancer. Cancer Treatment Reviews, 111, Article ID: 102480. https://doi.org/10.1016/j.ctrv.2022.102480 |
[19] | Lepore Signorile, M., Grossi, V., Fasano, C. and Simone, C. (2023) Colorectal Cancer Chemoprevention: A Dream Coming True? International Journal of Molecular Sciences, 24, Article No. 7597.
https://doi.org/10.3390/ijms24087597 |
[20] | Aljama, S., Lago, E.P., Zafra, O., et al. (2023) Dichotomous Colorectal Cancer Behaviour. Critical Reviews in Oncology/Hematology, 189, Article ID: 104067. https://doi.org/10.1016/j.critrevonc.2023.104067 |
[21] | Gogoi, P., Kaur, G. and Singh, N.K. (2022) Nanotechnology for Colorectal Cancer Detection and Treatment. World Journal of Gastroenterology, 28, 6497-6511. https://doi.org/10.3748/wjg.v28.i46.6497 |
[22] | Kastrinos, F., Kupfer, S.S. and Gupta, S. (2023) Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology, 164, 812-827.
https://doi.org/10.1053/j.gastro.2023.02.021 |
[23] | Ballester, V. and Cruz-Correa, M. (2022) Approach to Familial Predisposition to Colorectal Cancer. Gastroenterology Clinics of North America, 51, 593-607. https://doi.org/10.1016/j.gtc.2022.06.001 |
[24] | Holm, T. (2014) Controversies in Abdominoperineal Excision. Sur-gical Oncology Clinics of North America, 23, 93-111.
https://doi.org/10.1016/j.soc.2013.09.005 |
[25] | Andrade-Meza, A., Arias-Romero, L.E., Armas-López, L., et al. (2023) Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies. International Journal of Molecular Sciences, 24, Article No. 2115. https://doi.org/10.3390/ijms24032115 |
[26] | Yamada, K., Ogata, S., Saiki, Y., Fukunaga, M., Tsuji, Y. and Takano, M. (2009) Long-Term Results of Intersphincteric Resection for Low Rectal Cancer. Diseases of the Colon and Rectum, 52, 1065-1071.
https://doi.org/10.1007/DCR.0b013e31819f5fa2 |
[27] | Feizi, H., Rezaee, M.A., Ghotaslou, R., et al. (2023) Gut Microbiota and Colorectal Cancer Risk Factors. Current Pharmaceutical Biotechnology, 24, 1018-1034. https://doi.org/10.2174/1389201023666221005103340 |
[28] | Wu, Y., Xie, M., Sun, J.H., et al. (2022) Cellular Se-nescence: A Promising Therapeutic Target in Colorectal Cancer. Future Oncology, 18, 3463-3470. https://doi.org/10.2217/fon-2021-0661 |
[29] | Nagayama, S., Al-Kubati, W. and Sakai, Y. (2012) What Is the Place of Intersphincteric Resection When Operating on Low Rectal Cancer? ISRN Surgery, 2012, Article ID: 585484. https://doi.org/10.5402/2012/585484 |
[30] | Leowattana, W., Leowattana, P. and Leowattana, T. (2023) Systemic Treatment for Metastatic Colorectal Cancer. World Journal of Gastroenterology, 29, 1569-1588. https://doi.org/10.3748/wjg.v29.i10.1569 |
[31] | Tufail, M. (2023) HOTAIR in Colorectal Cancer: Structure, Func-tion, and Therapeutic Potential. Medical Oncology, 40, Article No. 259. https://doi.org/10.1007/s12032-023-02131-5 |
[32] | Shihab, O.C., Moran, B.J., Heald, R.J., Quirke, P. and Brown, G. (2009) MRI Staging of Low Rectal Cancer. European radiology, 19, 643-650. https://doi.org/10.1007/s00330-008-1184-6 |
[33] | Niekamp, P. and Kim, C.H. (2023) Microbial Metabolite Dysbio-sis and Colorectal Cancer. Gut and Liver, 17, 190-203.
https://doi.org/10.5009/gnl220260 |
[34] | Yu, H.C., Peng, H., He, X.S. and Zhao, R.S. (2014) Comparison of Short- and Long-Term Outcomes after Extralevator Abdominoperineal Excision and Standard Abdominoperineal Excision for Rectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Colorectal Disease, 29, 183-191. https://doi.org/10.1007/s00384-013-1793-7 |
[35] | Daca-Alvarez, M., Martí, M., Spinelli, A., et al. (2022) Familial Component of Early-Onset Colorectal Cancer: Opportunity for Prevention. British Journal of Surgery, 109, 1319-1325. https://doi.org/10.1093/bjs/znac322 |
[36] | Liu, Y., Lau, H.C., Cheng, W.Y. and Yu, J. (2023) Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Genomics Proteomics Bioinformatics, 21, 84-96. https://doi.org/10.1016/j.gpb.2022.07.002 |
[37] | Dougherty, M.W. and Jobin, C. (2023) Intestinal Bacteria and Col-orectal Cancer: Etiology and Treatment. Gut Microbes, 15, Article ID: 2185028. https://doi.org/10.1080/19490976.2023.2185028 |
[38] | How, P., West, N.P. and Brown, G. (2014) An MRI-Based Assessment of Standard and Extralevator Abdominoperineal Excision Specimens: Time for a Patient Tailored Approach? Annals of Surgical Oncology, 21, 822-828.
https://doi.org/10.1245/s10434-013-3378-7 |
[39] | Laurberg, S. and Feddern, M.-L. (2015) Reconstructions after Neoadjuvant and Abdominoperineal Resection. In: Baatrup, G., Ed., Multidisciplinary Treatment of Colorectal Cancer, Springer International Publishing, Berlin, 99-104.
https://doi.org/10.1007/978-3-319-06142-9_11 |
[40] | Hu, B., Yin, Y., Li, S. and Guo, X. (2022) Insights on Fer-roptosis and Colorectal Cancer: Progress and Updates. Molecules, 28, Article No. 243. https://doi.org/10.3390/molecules28010243 |
[41] | Chen, L.J., Chen, X., Niu, X.H. and Peng, X.F. (2023) LncRNAs in Colorectal Cancer: Biomarkers to Therapeutic Targets. Clinica Chimica Acta, 543, Article ID: 117305. |
[42] | Lulli, M., Napoli, C., Landini, I., Mini, E. and Lapucci, A. (2022) Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. International Journal of Molecular Sciences, 23, Article No. 13431.
https://doi.org/10.3390/ijms232113431 |
[43] | Bastid, C., Coron, E., Meyer, J., Ris, F., Meurette, G. and Koessler, T. (2023) Cancer Colorectal: Révolution Technologique [Colorectal Cancer: Technological Revolution]. Revue Médicale Suisse, 19, 938-943.
https://doi.org/10.53738/REVMED.2023.19.827.938 |
[44] | Saraiva, M.R., Rosa, I. and Claro, I. (2023) Early-Onset Colorectal Cancer: A Review of Current Knowledge. World Journal of Gastroenterology, 29, 1289-1303. https://doi.org/10.3748/wjg.v29.i8.1289 |
[45] | Petrick, J.L., Barber, L.E. and Rosenberg, L. (2022) What Are the Factors Underlying Colorectal Cancer Health Disparities? Cancer Prevention Research (Phila), 15, 561-563. https://doi.org/10.1158/1940-6207.CAPR-22-0292 |
[46] | Lim, R.S., Yang, T.X. and Chua, T.C. (2014) Postopera-tive Bladder and Sexual Function in Patients Undergoing Surgery for Rectal Cancer: A Systematic Review and Me-ta-Analysis of Laparoscopic versus Open Resection of Rectal Cancer. Techniques in Coloproctology, 18, 993-1002. https://doi.org/10.1007/s10151-014-1189-x |
[47] | Caspi, A., Entezari, A.A., Crutcher, M., Snook, A.E. and Wald-man, S.A. (2022) Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer. Personalized Medicine, 19, 457-472.
https://doi.org/10.2217/pme-2022-0026 |
[48] | Sartore-Bianchi, A., Agostara, A.G., Patelli, G., Mauri, G., et al. (2022) Application of Histology-Agnostic Treatments in Metastatic Colorectal Cancer. Digestive and Liver Disease, 54, 1291. https://doi.org/10.1016/j.dld.2022.05.013 |
[49] | Liu, Z., Xiang, Y., Zheng, Y. and Kang, X. (2022) Advancing Immune Checkpoint Blockade in Colorectal Cancer Therapy with Nanotechnology. Frontiers in Immunology, 13, Article ID: 1027124.
https://doi.org/10.3389/fimmu.2022.1027124 |
[50] | Ma, Y., Wang, B., He, P., et al. (2022) Coagulation- and Fibri-nolysis-Related Genes for Predicting Survival and Immunotherapy Efficacy in Colorectal Cancer. Frontiers in Immunology, 13, Article ID: 1023908.
https://doi.org/10.3389/fimmu.2022.1023908 |
[51] | Baraibar, I., Ros, J., Saoudi, N., et al. (2023) Sex and Gender Perspectives in Colorectal Cancer. ESMO Open, 8, Article ID: 101204. https://doi.org/10.1016/j.esmoop.2023.101204 |
[52] | Johansson, M. (2023) The Questionable Value of Colorectal Cancer Screening. BMJ, 380, Article No. 200.
https://doi.org/10.1136/bmj.p200 |
[53] | Duek, S.D., Issa, N., Hershko, D.D. and Krausz, M.M. (2008) Outcome of Transanal Endoscopic Microsurgery and Adjuvant Radiotherapy in Patients with T2 Rectal Cancer. Diseases of the Colon and Rectum, 51, 379-384.
https://doi.org/10.1007/s10350-007-9164-5 |
[54] | Elwali, N.E., Jarrah, O., Alzahrani, S.G., et al. (2023) Colorectal Cancer in Saudi Arabia: The Way Forward. Asian Pacific Journal of Cancer Prevention, 24, 13-19. https://doi.org/10.31557/APJCP.2023.24.1.13 |
[55] | Sajid, M.S., Farag, S., Leung, P., Sains, P., Miles, W.F. and Baig, M.K. (2014) Systematic Review and Meta-Analysis of Published Trials Comparing the Effectiveness of Transanal Endoscopic Microsurgery and Radical Resection in the Management of Early Rectal Cancer. Colorectal Disease: The Of-ficial Journal of the Association of Coloproctology of Great Britain and Ireland, 16, 2-14. https://doi.org/10.1111/codi.12474 |
[56] | Rahmani, N., Pourali, G., Hosseini, N., et al. (2023) Probiotics as a Ther-apeutic Approach in Colorectal Cancer. Current Cancer Drug Targets, 23, 764-777. https://doi.org/10.2174/1568009623666230413081513 |
[57] | Wang, X., Xu, Y., Dai, L., et al. (2022) A Novel Ox-idative Stress- and Ferroptosis-Related Gene Prognostic Signature for Distinguishing Cold and Hot Tumors in Colorectal Cancer. Frontiers in Immunology, 13, Article ID: 1043738.
https://doi.org/10.3389/fimmu.2022.1043738 |
[58] | Seva-Pereira, G. and Trombeta, V.L., Capochim Romagnolo, L.G. (2014) Transanal Minimally Invasive Surgery (TAMIS) Using a New Disposable Device: Our Initial Experience. Techniques in Coloproctology, 18, 393-397.
https://doi.org/10.1007/s10151-013-1036-5 |
[59] | Martin-Perez, B., Andrade-Ribeiro, G.D., Hunter, L. and Atallah, S. (2014) A Systematic Review of Transanal Minimally Invasive Surgery (TAMIS) from 2010 to 2013. Techniques in Coloproctology, 18, 775-788.
https://doi.org/10.1007/s10151-014-1148-6 |
[60] | Krishnan, T., Wang, F., Karapetis, C., Roy, A. and Price, T. (2023) Primary Site and Treatment Impact in Unresectable Metastatic Colorectal Cancer. Expert Review of Anticancer Therapy, 23, 617-623.
https://doi.org/10.1080/14737140.2023.2208353 |
[61] | Ameen, S., Wong, M.C., Turner, P. and Yee, K.C. (2023) Improving Colorectal Cancer Screening-Consumer-Centred Technological Interventions to Enhance Engagement and Par-ticipation amongst Diverse Cohorts. Clinics and Research in Hepatology and Gastroenterology, 47, Article ID: 102064. https://doi.org/10.1016/j.clinre.2022.102064 |
[62] | Chiu, L.S. and Calderwood, A.H. (2023) Noninvasive Colorectal Cancer Prevention Options in Older Adults. Journal of Clinical Gastroenterology, 57, 855-862. https://doi.org/10.1097/MCG.0000000000001893 |
[63] | Phen, C., Berens, D., Moriarty, K., Ng, K., Sengupta, A. and Rojas, I. (2022) Polygenic Early-Onset Colorectal Cancer in Pediatric Patients. Pediatric Blood & Cancer, 69, e29790. https://doi.org/10.1002/pbc.29790 |
[64] | Liu, T.Y., Hu, C.C., Han, C.Y., et al. (2023) IGF2BP2 Promotes Colorectal Cancer Progression by Upregulating the Expression of TFRC and Enhancing Iron Metabolism. Biology Di-rect, 18, Article No. 19.
https://doi.org/10.1186/s13062-023-00373-x |
[65] | Taglialegna, A. (2023) Commensal Bacteria Fight Colorectal Cancer. Nature Reviews Microbiology, 21, Article No. 276. https://doi.org/10.1038/s41579-023-00887-1 |
[66] | Puli, A.V., Lussiez, A., MacEachern, M., et al. (2023) Barriers to Colorectal Cancer Screening in US Immigrants: A Scoping Review. Journal of Surgical Research, 282, 53-64. https://doi.org/10.1016/j.jss.2022.08.024 |
[67] | Graham, H., Kauffman, R. and Khaliq, W. (2022) Colorectal Cancer Screening Prevalence, Perceived Barriers, and Preference for Screening Colonoscopy among Hospitalized Women. Turkish Journal of Gastroenterology, 33, 901-908.
https://doi.org/10.5152/tjg.2022.21567 |
[68] | Jiang, Z., Sha, G., Zhang, W., et al. (2023) The Huge Potential of Tar-geting Copper Status in the Treatment of Colorectal Cancer. Clinical and Translational Oncology, 25, 1977-1990. https://doi.org/10.1007/s12094-023-03107-7 |
[69] | Liang, Z., Xie, H., Shen, W., et al. (2022) The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis. Frontiers in Bioscience (Landmark Ed), 27, Article No. 263.
https://doi.org/10.31083/j.fbl2709263 |
[70] | Marks, J.H., Frenkel, J.L., D’Andrea, A.P. and Greenleaf, C.E. (2011) Maximizing Rectal Cancer Results: TEM and TATA Techniques to Expand Sphincter Preservation. Surgical Oncology Clinics of North America, 20, 501-520.
https://doi.org/10.1016/j.soc.2011.01.008 |
[71] | Zhang, H., Zhang, Y.S., Jin, X.W., Li, M.Z., Fan, J.S. and Yang, Z.H. (2013) Transanal Single-Port Laparoscopic Total Mesorectal Excision in the Treatment of Rectal Cancer. Techniques in Coloproctology, 17, 117-123.
https://doi.org/10.1007/s10151-012-0882-x |
[72] | de Lacy, A.M., Rattner, D.W., Adelsdorfer, C., et al. (2013) Transanal Natural Orifice Transluminal Endoscopic Surgery (NOTES) Rectal Resection: “Down-to-Up” Total Mesorectal Excision (TME) Short-Term Outcomes in the First 20 Cases. Surgical Endoscopy, 27, 3165-3172. https://doi.org/10.1007/s00464-013-2872-0 |
[73] | Kano, Y., Suenaga, M. and Uetake, H. (2023) Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer. Current Oncology, 30, 6546-6558. https://doi.org/10.3390/curroncol30070480 |
[74] | Lin, W.C., Lin, C.C., Lin, Y.Y., et al. (2022) Molecular Actions of Exosomes and Their Theragnostics in Colorectal Cancer: Current Findings and Limitations. Cellular Oncology (Dordr), 45, 1043-1052.
https://doi.org/10.1007/s13402-022-00711-7 |
[75] | Atallah, S., Martin-Perez, B., Albert, M., et al. (2014) Transanal Minimally Invasive Surgery for Total Mesorectal Excision (TAMIS-TME): Results and Experience with the First 20 Pa-tients Undergoing Curative-Intent Rectal Cancer Surgery at a Single Institution. Techniques in Coloproctology, 18, 473-480. https://doi.org/10.1007/s10151-013-1095-7 |